1. Home
  2. Products
  3. Customized FluoroAb™
  4. IFNG
  5. Anti-IFNG MAb (Clone 1)-iFluor® 460 Succinimidyl Ester

Anti-IFNG MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8297)

This product is comprised of an Humanized Anti-IFNG IgG1 antibody (Clone 1) labeled with iFluor® 460 Succinimidyl Ester. iFluor® 460 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • IFNG
  • Alternative Names
  • GD2
  • Overview
  • GD2 is a disialoganglioside expressed in tumors of neuroectodermal origin (including human neuroblastoma and melanoma), and its expression in normal tissues (mainly human cerebellum and peripheral nerves) is highly restricted.

    The relative tumor-specific expression of GD2 makes it a suitable target for immunotherapy using monoclonal antibodies or artificial T cell receptors. An example of such an antibody is hu14.18K322A, a monoclonal antibody. The anti-GD2 antibody is currently in phase II clinical trials for the treatment of previously untreated high-risk neuroblastoma and combined chemotherapy prior to stem cell transplantation and radiation therapy. A previous phase I clinical trial designed to reduce toxicity in patients with refractory or recurrent neuroblastoma found a safe dose and determined that common toxicity, especially pain, can be well controlled.
  • Overview
  • Humanized Anti-IFNG IgG1 antibody (Clone 1)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 460 Succinimidyl Ester
  • Color
  • Green
  • Excitation⁄Emission (nm)
  • 468/493
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS8297. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-1227 Anti-IFNG (Crenezumab)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
ADC-W-1226 Anti-IFNG (Crenezumab)-SMCC-DM1 ADC SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-1231 Anti-IFNG (Crenezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA
ADC-W-1229 Anti-IFNG (Crenezumab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE
ADC-W-1228 Anti-IFNG (Crenezumab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF

Online Inquiry

Name:
Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.